Depakote ER OK'd for symptoms of bipolar disorder

The FDA has given the nod to Abbott's Depakote ER (divalproex sodium) tablets for the treatment of mania or mixed episodes with or without psychotic features associated with bipolar disorder. Depakote ER is the once-daily formulation of Depakote tablets, which has been a treatment for bipolar disorder since its approval in 1995.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.